Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Optometry Retina Trauma/Surgery Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login

Recognition and Referral: Best Practices for Managing Patients with GA

By: Roger A. Goldberg, MD, MBA

Webinar Credits: 1.25

Patients with advanced dry age-related macular degeneration can present with geographic atrophy (GA), a disease that is progressive and increases with age. Although there is no treatment approved by the FDA that halts or reverses GA, a number of drugs in the pipeline are designed to address GA progression, hoping to succeed where previous drug candidates failed. This series of regional, interactive, virtual symposia are designed to educate eye care providers on the importance of diagnosis and potential treatment options so they may plan accordingly for the best possible care of patients with GA.

This educational activity is designed for optometrists and general ophthalmologists.

Expiration Date: Saturday, November 16, 2024
Release Date: November 22, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the prevalence of age-related macular degeneration
  • Articulate the burden of illness linked to geographic atrophy (GA)
  • Understand the pathogenesis of GA
  • Describe disease detection and factors influencing progression
  • Review the therapeutic interventions that have been explored as well as those in the pipeline

Accreditation and Designation Statement

Provided by Evolve Medical Education 


Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Sponsored by

Evolve is an approved COPE Administrator. This activity, COPE Activity Number 122939, is accredited by COPE for continuing education for optometrists for 1.25 hours.
COPE Course ID75625-PS
COPE Activity ID: 122939

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Roger A. Goldberg, MD, MBA

Vitreoretinal Specialist
Bay Area Retina Associates
Walnut Creek, CA
Volunteer Faculty
California Pacific Medical Center
Ophthalmology Residency
San Francisco, CA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Roger A. Goldberg, MD, MBA,  has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Genentech, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Aerie Pharmaceuticals, Allergan, Apellis Pharmaceuticals, Carl Zeiss Meditec, Chengdu Kanghong Biotechnology, Genentech, Graybug Vision, Neurotech, Novartis, Ribomics, and Santen. Speaker’s Bureau: Allergan and Genentech.

The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis Pharmaceuticals.

Begin Course